T&L Co., Ltd. (KOSDAQ:340570)

Market Cap	379.99B -0.1%
Revenue (ttm)	175.16B -5.5%
Net Income	50.78B +11.2%
EPS	3,161.87 +11.8%
Shares Out	16.00M
PE Ratio	7.51
Forward PE	6.00
Dividend	750.00 (3.16%)
Ex-Dividend Date	Dec 29, 2025

Volume	28,737
Open	23,700
Previous Close	24,250
Day's Range	23,350 - 24,300
52-Week Range	21,550 - 35,800
Beta	0.34
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About T&L Co., Ltd.

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 250
• Stock Exchange: KOSDAQ
• Ticker Symbol: 340570

Financial Performance

In 2025, T&L Co., Ltd.'s revenue was 164.16 billion, a decrease of -6.14% compared to the previous year's 174.89 billion. Earnings were 38.07 billion, a decrease of -17.96%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 30, 2026

Data Sources Report a data error